News

Pan-European APPROACH project receives 15 million Euro research funding to find the right osteoarthritis medicine for the right patient

- In a bid to stimulate the development of much needed treatments for osteoarthritis, a consortium of 24 partners comprising pharmaceutical companies, biotech companies, academic institutions, not-for-profit organizations, small and medium enterprises (SMEs) and public bodies have joined forces in the pan-European APPROACH (Applied Public-Private Research enabling OsteoArthritis Clinical Headway) project, with total research funding of 15 million Euros.

Amgen to Aquire Privately-held Dezima Pharma

- Amgen (NASDAQ:AMGN) and Dezima Pharma B.V. (Dezima) announced that the companies have entered into a definitive acquisition agreement under which Amgen will acquire Dezima, a privately-held, Netherlands-based biotechnology company focused on developing innovative treatments for dyslipidemia. Dezima shareholders have approved the agreement.

Barend Mons appointed Chair of European Commission’s high level expert group on ‘European Open Science Cloud’

- Professor Barend Mons has been appointed Chair of the Commission High Level Expert Group "European Open Science Cloud", initiated by the European Commission, DG Research and Innovation.

Kite Pharma Expands Collaboration With Netherlands Cancer Institute (NKI)

- Kite Pharma announced that it has expanded its collaboration with the Netherlands Cancer Institute (NKI). Kite and the NKI have entered into an agreement under which Kite will receive from the NKI the exclusive option to license multiple T cell receptor (TCR) gene sequences for the development and commercialization of cancer immunotherapy candidates targeting solid tumors.

New publication: Health~Holland Guide 2015-2016

- The Task Force Health Care and Health~Holland present the third edition of the Health~Holland Guide.

A big data approach leads to undiscovered insights into ALS

- This summer nine Master / PhD students from various disciplines travelled to New York, Boston, Portugal, Spain and The Netherlands with the goal to develop new insights into ALS in order to speed up the discovery of therapeutics.

New Friends: First International Conference on Social Robots in Therapy and Education

- Op 22 en 23 oktober vindt de eerste internationale conferentie over sociale robots in therapie en educatie plaats. De conferentie wordt georganiseerd door een internationaal consortium van universiteiten en hogescholen onder leiding van Lectoraat Robotica van Windesheim Flevoland in Almere.

Health~Holland Update, September 2015

- We are pleased to present you the fourth edition of the bimonthly Health~Holland Update, our magazine that brings you the latest insights and developments from Health~Holland (Top Sector Life Sciences & Health).

TI Pharma coordinates European Research on Market Access innovative medicine

- Escher – het TI Pharma platform voor regulatoire innovatie – leidt het onderzoek in goede banen en zet Nederland internationaal op de kaart als gesprekspartner in geneesmiddelenregulering.

King William I Prize and King William I Plaque for Sustainable Entrepreneurship 2016

- Vanaf 1 september 2015, is het voor Nederlandse ondernemingen weer mogelijk zich in te schrijven voor de Koning Willem I Prijs en de Koning Willem I Plaquette voor Duurzaam Ondernemerschap. Deze prijzen worden in mei 2016 wederom uitgereikt door Hare Majesteit Koningin Máxima en Prof. Dr. K.H.W. Knot, President van De Nederlandsche Bank N.V. en voorzitter van de Koning Willem I Stichting.